The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial - Wikidata - wikimedia - TriplyDB

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial

http://www.wikidata.org/entity/Q24630475

about

Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?Chondroitin for osteoarthritis Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties Nutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritis Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial Disease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation.First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort.Long-Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six-Year Followup Data From the Osteoarthritis Initiative.10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin Relationship between radiographic changes and symptoms or physical examination findings in subjects with symptomatic medial knee osteoarthritis: a three-year prospective study.Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study.A peptidyl-glucosamine derivative affects IKKalpha kinase activity in human chondrocytes Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis Progress in complementary and alternative medicine research: Yale Research Symposium on Complementary and Integrative Medicine.Comparative therapeutic efficacy and safety of type-II collagen (UC-II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate.Role of glucosamine in the treatment for osteoarthritis Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials.Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens.Management of Osteoarthritis with Avocado/Soybean Unsaponifiables.Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA.Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI How to find nothing.Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis.Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritis A randomized comparative study of safety and efficacy of immediate release glucosamine HCL and glucosamine HCL sustained release formulation in the treatment of knee osteoarthritis: A proof of concept study Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis Current evidence for osteoarthritis treatments.Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations.Efficacy of pulsed Nd:YAG laser in the treatment of patients with knee osteoarthritis: a randomized controlled trial.How to define responders in osteoarthritis.Knee osteoarthritis diagnosis, treatment and associated factors of progression: part II.Quality of different chondroitin sulfate preparations in relation to their therapeutic activity.FlexPro MD, a Mixture of Krill Oil, Astaxanthin, and Hyaluronic Acid, Suppresses Lipopolysaccharide-Induced Inflammatory Cytokine Production Through Inhibition of NF-κB.

P2860

Q21195259-E386C8DA-2251-4CCB-9EFC-7A43247EFEF1 Q24186473-279C584F-DAD2-4DAD-9CB3-3BF72AFD67F5 Q24602794-D4F4249E-DCD4-4032-A2DA-C23D1A58D3CC Q24606203-88B4773B-761B-4DCB-8ABB-BEB2325D2AD0 Q24630093-CDF5FB50-9604-4F6A-8021-64E15F3EE74E Q24630640-5812CD39-1318-4254-957E-5352406D1CDD Q26860861-D1F6EBB5-6806-4717-B204-BC28E967B3F2 Q28081360-4971B0BD-300E-48AD-9FA4-2C3AD7DB30B6 Q28278433-B3C03555-7E81-48AB-A60F-C5A9667B72CB Q30588700-7C5DBDB3-34A9-48D2-8078-BE9D0A25CDAB Q30714596-B5A2F047-520E-4CE8-A522-22930BF87974 Q31046250-CA320D30-958A-4FB0-8526-5D6FFD1CCD41 Q33678954-B7EE9D4A-7674-492D-92B9-D5CE019C1C04 Q33752290-C360AF21-C21F-4D27-A041-730F0767EEF0 Q33845330-22EAF47B-88C3-455F-B834-0582CC4B9DE0 Q33873693-829FD354-0484-48C6-AC6B-61AB08E4B964 Q33920880-0B33498C-6E36-4C02-B452-45DBDD62752E Q34069452-4D231424-7FEC-4ECE-BDC2-5814BD5ABD04 Q34157463-36B6D3AE-07CA-4DB7-9CF4-CC7017BDDF38 Q34188301-45A38302-6559-44D6-8BCC-DB44B20BAC21 Q34264613-2F6CC92C-575D-42B9-8D50-28C2669067A0 Q34345032-2040693A-3F51-42EB-AEDE-41C4400E6025 Q34396147-5E1DC181-AE1A-44C9-97B6-7CFAF4255FC4 Q34459643-397AB4A5-CB27-4D1D-AC42-800E806BFAC4 Q34605944-56BFCF5F-50BA-46D1-98D2-C50A4602AE57 Q34906145-46335BE8-5FC2-48FD-979E-99CB99032AA1 Q35006721-247A67B6-8B53-4FEF-B186-D3C6ED5A54CB Q35125975-71E87B36-A288-4D5B-9BF3-CB76B44B6A32 Q35147261-DB088543-2FC2-4784-BEA8-935F331B594C Q35197151-5C9A1136-7BEE-42BA-A1BF-C47B3D3C06E0 Q35678484-27467E0B-A8EE-44BA-8BA2-DF12388133CE Q35770645-D7422C44-9A48-4A19-9B1D-824B90D23B53 Q35840709-302E33C0-43D3-470D-A55B-C9AD8DC0C0BC Q36059344-9477E7E7-6FC7-4B0F-A02D-FE7CCAA1513C Q36059429-A77BB7F5-AB4C-4DC7-9E95-8897DAF60230 Q36247005-C5F971BA-3B8D-4B1F-86D0-795DF1306046 Q36949072-AFBF0CAF-9461-475B-93F7-A3B6CFE769FD Q37164156-A7F82E48-C7AD-414B-87BA-59885AD78FB9 Q37611121-38D1133C-F59A-4656-8C3A-9BAEF01A2FE3 Q37645550-3DDB1E44-500B-495B-90F6-A209A55C50E2

P2860

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial

http://www.wikidata.org/entity/Q24630475

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The effect of glucosamine and/ ...... n arthritis intervention trial

@ast

The effect of glucosamine and/ ...... n arthritis intervention trial

@en

The effect of glucosamine and/ ...... n arthritis intervention trial

@nl

type

label

The effect of glucosamine and/ ...... n arthritis intervention trial

@ast

The effect of glucosamine and/ ...... n arthritis intervention trial

@en

The effect of glucosamine and/ ...... n arthritis intervention trial

@nl

prefLabel

The effect of glucosamine and/ ...... n arthritis intervention trial

@ast

The effect of glucosamine and/ ...... n arthritis intervention trial

@en

The effect of glucosamine and/ ...... n arthritis intervention trial

@nl

P1433

Q24630475-3866A533-98EF-4AB8-A3CA-BCDFE8F4A658

P1476

Q24630475-9630C3EA-4E70-47CB-9236-3D5AFA6A699F

P2093

Q24630475-0035A269-5F1B-4088-A9C2-BEC1B0107897

Q24630475-0466896D-3B93-4306-A8FE-6785D5597E29

Q24630475-09E80297-AB8C-4F04-9247-1FFBDC607370

Q24630475-2013CE91-766D-447C-BB83-B0FFEAFA80DC

Q24630475-37DC7DA0-9963-453D-BD00-C15912125236

Q24630475-37E9442F-14A9-4378-AB14-17AD2322C5B5

Q24630475-5E67208F-6ACB-449C-80FE-E466425E9946

Q24630475-66613F7B-0123-4065-8D59-6912AF5C67C1

Q24630475-69275F7E-5236-4F19-9A62-EAFA5E7ED9E2

Q24630475-77E60DC8-DCD3-4A20-9DEA-2F879B37E7CF

P2860

Q24630475-0244152E-1752-4E6D-849A-BC97A96CE086

Q24630475-095FAD21-99BE-4C96-BDC7-6EEF88FE6141

Q24630475-09A48FE8-6BB1-4A7D-BB6D-EFD84C640ABF

Q24630475-131414CA-E7AF-4FF9-B9ED-734410630A16

Q24630475-199CCECB-B6C2-43F5-90F3-5BBF763AFB57

Q24630475-1B539623-DB0F-409F-AA68-C6B03B616827

Q24630475-23C5CFC7-70D7-4DD3-9597-D74A361BD784

Q24630475-2499D15A-EFD0-4AE6-8B70-2B94CBC3FF84

Q24630475-29709182-E9B5-4DEF-8E15-076F788AF20F

Q24630475-43B29FB7-647D-4E85-A940-F8AE69118534

P304

Q24630475-11A40E90-C648-4F80-806D-E76496A02921

P31

Q24630475-3F0A453D-8240-4B42-8367-C40698C23E95

P3181

Q24630475-C6F22862-6ED0-41E0-BF82-9988B076A481

P356

Q24630475-DCCE6356-335D-4D48-A8B5-E26A0A466A8A

P407

Q24630475-2579C4B1-33F9-4817-AA36-AED3D7C7EA23

P433

Q24630475-C13CF99F-BCEB-43CD-B4B1-F74A83BE9A90

P478

Q24630475-8A733764-D22D-4DCA-82E2-D7A365E57938

P50

Q24630475-6BCD20E7-EAB2-442D-9179-C07D86EA7758

P577

Q24630475-88BFDEA6-C26A-4099-B2D3-3CC554A5DB07

P5875

Q24630475-F0201238-514D-4C15-8AF0-CA9FEFC30738

P698

Q24630475-51F8ADE3-943A-43DE-9211-E447F651F112

P921

Q24630475-4CB1147D-46E2-44D7-A7A2-0806E3E2E383

P932

Q24630475-F9A77AEA-C1B7-4FA8-A44B-B89F57113DB1

P3181

P356

P1433

Arthritis and Rheumatism

P1476

The effect of glucosamine and/ ...... n arthritis intervention trial

@en

P2093

Allen D Sawitzke

http://www.w3.org/2001/XMLSchema#string

Chester V Oddis

http://www.w3.org/2001/XMLSchema#string

Christopher G Jackson

http://www.w3.org/2001/XMLSchema#string

Clifton O Bingham

http://www.w3.org/2001/XMLSchema#string

Crystal L Harris

http://www.w3.org/2001/XMLSchema#string

Daniel E Furst

http://www.w3.org/2001/XMLSchema#string

Daniel O Clegg

http://www.w3.org/2001/XMLSchema#string

David Silver

http://www.w3.org/2001/XMLSchema#string

Domenic J Reda

http://www.w3.org/2001/XMLSchema#string

Dorothy D Dunlop

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

Radiological assessment of osteo-arthrosis

OsiriX: an open-source software for navigating in multidimensional DICOM images.

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients.

Osteoarthritis: new insights. Part 1: the disease and its risk factors.

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis.

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

P304

3183-3191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3365288

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ART.23973

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23288047

http://www.w3.org/2001/XMLSchema#string

P698

18821708

http://www.w3.org/2001/XMLSchema#string

P921

P932

2836125

http://www.w3.org/2001/XMLSchema#string